The Cross-Border Biotech Blog

Human POC

Check out the CTI Life Sciences Fund’s Janelle Anderson’s interview of Brian Bloom on the Human Proof Of Concept podcast by clicking on the image below.

read more


Screen Shot 2016-08-16 at 8.52.51 AM

Click on the link above to see a profile of the 5th Bloom Burton Healthcare Investor Conference on Business Television.

read more


Q2 2016_Part2-01

Tier 1 Canadian Healthcare Companies – Flat with less volatility In this blog, I am going to comment on the Q2 and H1 performances of the group of 56 companies with share prices of $1.00 or more to start 2016 (Stellar Biotechnologies dropped from assessment). Advancers slightly outnumbered decliners by 29 to 27 Average and […]

read more


Q2 2016_Part1-01

Overall, Q2 2016 share price performance in the sector was slightly positive for the companies starting 2015 with share prices of $0.10 or higher. Two companies have been deleted from the analysis – DiagnoCure is undergoing voluntary liquidation and dissolution and Stellar Biotechnologies delisted from the TSX and no longer has any Canadian link. Advancers […]

read more


SharePricePerformance_ViolatileandNegagiveinQ1_Part3-01

Tier 2 Canadian Healthcare Companies – negative but no panic (same as Tier 1) In this blog, I am going to comment on the Q1 2016 share price performance of the group of 61 companies with share prices of between $0.10 and $0.99 to start 2016. Decliners outnumbered advancers by 36 to 25 (better than […]

read more


SharePricePerformance_ViolatileandNegagiveinQ1_Part2-01

Tier 1 Canadian Healthcare Companies – negative but no panic In this blog, I am going to comment on the Q1 performance of the group of 55 companies with share prices of $1.00 or more to start 2016. Decliners doubled the number of advancers by 37 to 18 Average and median share price changes were […]

read more


Screen Shot 2016-05-17 at 9.10.21 AM

Bloom Burton & Co. President also provides his sector outlook, advice for investors and top healthcare stock picks Click on the image to view the full video.

read more


SharePricePerformance_ViolatileanNegagiveinQ1_Part1-01

In order to assess share price performance among the Canadian public healthcare companies, I select companies at the beginning of each year which are categorized in two ways: share price to start the year and type of company. The total number of companies which will be assessed on a quarterly basis has increased from 99 […]

read more


Screen Shot 2016-05-01 at 9.54.42 PM

Brian Bloom discusses challenges facing Canada’s healthcare industry in Valeant’s shadow Click on the image to view the full video.

read more


Bloom Burton opens the TSX 2016

Bloom Burton opens the TSX ahead of the 2016 Bloom Burton Healthcare Investment Conference Click on the image to view the full video.

read more